Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Nevro's Pre-Tax Income for the
three
months ended in Mar. 2024 was $-25.0 Mil. Nevro's Revenue for the
three
months ended in Mar. 2024 was $101.9 Mil. Therefore, Nevro's pretax margin for the quarter that ended in Mar. 2024 was -24.56%.
The historical rank and industry rank for Nevro's Pretax Margin % or its related term are showing as below:
NVRO'
s Pretax Margin % Range Over the Past 10 Years
Min: -95.2 Med: -22.86 Max: 1.05
Current: -20.47
NVRO's Pretax Margin % is ranked worse than 60.76% of 818
companies
in the Medical Devices & Instruments industry
Industry Median: 0
vs NVRO: -20.47
Nevro Pretax Margin % Historical Data
The historical data trend for Nevro's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Nevro's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nevro's Pretax Margin % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nevro's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Nevro's Pretax Margin % falls into.
Nevro Pretax Margin % Calculation
Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.
Nevro's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nevro (NYSE:NVRO) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Nevro Pretax Margin % Related Terms
Thank you for viewing the detailed overview of Nevro's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Nevro Corp is a medical device company. Its key product is the HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. The company generates the majority of its revenue in the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NVRO has been successfully added to your 